Pirfenidone Tablets - Effective Treatment for Idiopathic Pulmonary Fibrosis
ProcurenetShort description
Pirfenidone Tablets are a pharmaceutical-grade remedy for mild and moderate idiopathic pulmonary fibrosis. Each tablet contains 200mg Pirfenidone, characterized by its potent anti-fibrotic and anti-inflammatory properties. Indications include:
- Mild and moderate idiopathic pulmonary fibrosis treatment
- Safe to ingest, either with food or alone, as prescribed by a healthcare professional
- Precautions against use in individuals with allergies to Pirfenidone or any constituent ingredient, and those pregnant or nursing
The product is stored in a cool, dry place and shielded from excessive heat and humidity. Manufactured in Beijing, our sales markets cover Central/South America, Western Europe, Asia, Middle East, Africa, and beyond. Note: Sample provision and payment terms subject to company policy.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Pirfenidone Tablets: A Key Treatment for Idiopathic Pulmonary Fibrosis
Pirfenidone is a well-recognized pharmaceutical drug, specially developed for the treatment of mild to moderate idiopathic pulmonary fibrosis. This specific form of drug comes in a 200mg tablet, ensuring easy administration and focused treatment for patients suffering from this medical condition.
- Compound Name: Pirfenidone
- IUPAC Name: 5-Methyl-1-phenyl-2(1H)-pyridone
- CAS Number: 53179-13-8
- Molecular Formula: C12H11NO
- Molecular Weight: 185.22 g/mol
- Hazard and Precautionary Statements: Use under medical supervision. Keep out of reach of children.
- Pharmacological Class: Antifibrotic agent
- Therapeutic Uses: Treatment for mild to moderate idiopathic pulmonary fibrosis
- Dosage: Administered orally. Consult your healthcare provider for personalized dosage information.
- Contraindications: Not suitable for patients allergic to Pirfenidone.
- Side Effects: May include nausea, fatigue, insomnia, rash, dyspepsia.
- Drug Interactions: Interactions may occur with CYP1A2 inhibitors. Always consult with your healthcare provider before starting any new medication.
Pirfenidone is a pharmaceutical grade product manufactured in a controlled setting. Its effectiveness in treating idiopathic pulmonary fibrosis makes it a preferred choice in diverse markets around the globe including Central/South America, Western Europe, Asia, the Middle East, and Africa.
Please note, this product is for professional use only and must be used under the guidance of a healthcare provider.
